Apap Tablet
Product Images NDC 17714-013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Apap (NDC 17714-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advance Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

De70766a-figure-01 (De70766a Figure 01)

De70766a-figure-01 (De70766a Figure 01)
This appears to be the description of a medication containing Acetaminophen. It is a pain reliever and fever reducer and helps relieve minor pains such as headaches, muscular aches, backaches, common colds, dental pain, and menstrual cramps. It is essential to take this medication after checking the recommended dosage as severe liver damage may occur due to overuse. This medication is manufactured by Advance Pharmaceuticals Inc.*
FDA Label Image

De70766a-figure-02 (De70766a Figure 02)

De70766a-figure-02 (De70766a Figure 02)
This is a continuation of the Drug Facts section that provides a set of guidelines for taking the medication safely. It cautions against using the drug with any other medication containing acetaminophen and recommends consulting a doctor or pharmacist if uncertain. Patients with allergies to acetaminophen or underlying liver diseases might need to seek medical advice before using this product. Anyone taking the blood-thinning drug warfarin should consult with a doctor or pharmacist before taking the medication. Individuals should stop using the drug if the pain gets severe or lasts more than ten days, and if they experience swelling or redness, which might suggest an underlying medical problem. Additionally, overdosing on the medication (taking more than the recommended dose) can be hazardous to individuals' liver health. The medication's ingestion directions are clearly highlighted, and patients should not exceed the recommended dosage of two tablets every six hours, not exceeding six tablets every 24 hours or beyond ten days unless directed by a physician. The medication should also be stored within the temperature range of 15°C and 30°C (59°F to 86°F), with a list of inactive ingredients provided.*
FDA Label Image

De70766a-figure-03 (De70766a Figure 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.